Miracle Grow condom gets a rise in company's stock

LONDON (Reuters) - British condom maker Futura Medical Plc said on Thursday that results of a study showed its new condom helped men have firmer and bigger erections, as well as a longer-lasting sexual experience.
Shares in the company, which specializes in sexual healthcare and pain relief, rose 14.5 percent to 59.25 pence on hopes the condom, which will be marketed by Durex condom-maker SSL International, could go on sale next year.
Futura said the study of 108 healthy couples showed its CSD500 condom helped men to get a firmer erection compared with a standard condom, increased penis size and made the sexual experience last longer, delivering statistically significant results.
The condom has a small amount of gel in its peak that dilates the arteries and increases blood flow to the penis.
Chief Executive James Barder said the study results underpinned hopes the contraceptive will start generating revenues in 2008.
Market research has shown so far that interest in the condom is enormous, Barder said.